This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bourne, R. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bourne, R. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery 82:1807 (2000)
© 2000 The Journal of Bone and Joint Surgery, Inc.

Evidence-Based Orthopaedics

Commentary

Robert B. Bourne, M.D., F.R.C.S.(C)

London Health Sciences Centre, University of Western Ontario

This study from the Pulmonary Embolism Prevention (PEP) Trial Collaborative Group provides sound evidence for routinely considering postoperative low-dose aspirin therapy as a prophylaxis against both PE and DVT for patients who have had operative treatment for hip fracture, total hip arthroplasty, or total knee replacement. The conclusions of this . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?